Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Baldoni currently holds 41,193 shares of MiNK Therapeutics, Inc. (INKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Baldoni has been a net neutral trader of INKT stock. They have purchased $0 and sold $0 worth of shares.
John Baldoni's most recent insider trade was on Sep 1, 2023, when they sold 9,846 shares at $1.46 per share.
John Baldoni serves as Executive at MiNK Therapeutics, Inc. (INKT). They have executed 5 insider transactions totaling $0 over their tenure at the company.
John Baldoni holds the position of Executive at MiNK Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
John Baldoni has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by John Baldoni was on Sep 15, 2022, when they purchased $28.8K worth of INKT shares. This transaction involved 10,974 shares at $2.62 per share.
John Baldoni currently owns 41,193 shares of MiNK Therapeutics, Inc. (INKT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Baldoni's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Baldoni has 5 Form 4 filings on record as an insider at MiNK Therapeutics, Inc..
Set alerts for John Baldoni and 40,000+ other insiders.